The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine

被引：0
|
作者：
Dong Wei
Weili Yu
Chunyang Hu
Lijuan Shen
Tao Hu
机构：
[1] Chinese Academy of Sciences,State Key Laboratory of Biochemical Engineering, Institute of Process Engineering
[2] University of Chinese Academy of Sciences,undefined
来源：
Biotechnology Letters | 2018年 / 40卷
关键词：
Capsular polysaccharide; Conjugate vaccine; Phenyl linker; Tetanus toxoid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1263 / 1270
页数：7
相关论文
共 50 条
  • [1] The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine
    Wei, Dong
    Yu, Weili
    Hu, Chunyang
    Shen, Lijuan
    Hu, Tao
    [J]. BIOTECHNOLOGY LETTERS, 2018, 40 (08) : 1263 - 1270
  • [2] Conjugation of PEG-hexadecane markedly increases the immunogenicity crossMark of pneumococcal polysaccharide conjugate vaccine
    Chang, Xin
    Yu, Weili
    Ji, Shaoyang
    Shen, Lijuan
    Tan, Aijuan
    Hu, Tao
    [J]. VACCINE, 2017, 35 (13) : 1698 - 1704
  • [3] PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine
    Huang, Qingrui
    Li, Dongxia
    Kang, Aijun
    An, Wenqi
    Fan, Bei
    Ma, Xiaowei
    Ma, Guanghui
    Su, Zhiguo
    Hu, Tao
    [J]. JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : 382 - 389
  • [4] Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine;: immunogenicity in patients with ataxia-telangiectasia
    Stray-Pedersen, A
    Aaberge, IS
    Früh, A
    Abrahamsen, TG
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 140 (03): : 507 - 516
  • [5] Pneumococcal polysaccharide conjugate vaccine
    不详
    [J]. AUSTRALIAN PRESCRIBER, 2010, 33 (02) : 56 - 57
  • [6] Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants
    Anderson, EL
    Kennedy, DJ
    Geldmacher, KM
    Donnelly, J
    Mendelman, PM
    [J]. JOURNAL OF PEDIATRICS, 1996, 128 (05): : 649 - 653
  • [7] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
    Jackson, Lisa A.
    Gurtman, Alejandra
    van Cleeff, Martin
    Jansen, Kathrin U.
    Jayawardene, Deepthi
    Devlin, Carmel
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    [J]. VACCINE, 2013, 31 (35) : 3577 - 3584
  • [8] Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants
    Nurkka, A
    Joensuu, D
    Henckaerts, I
    Peeters, P
    Poolman, J
    Kilpi, T
    Käyhty, H
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (11) : 1008 - 1014
  • [9] Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
    Glesby, Marshall J.
    Watson, Wendy
    Brinson, Cynthia
    Greenberg, Richard N.
    Lalezari, Jacob P.
    Skiest, Daniel
    Sundaraiyer, Vani
    Natuk, Robert
    Gurtman, Alejandra
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (01): : 18 - 27
  • [10] Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants
    Zangwill, KM
    Greenberg, DP
    Chiu, CY
    Mendelman, P
    Wong, VK
    Chang, SJ
    Partridge, S
    Ward, JI
    [J]. VACCINE, 2003, 21 (17-18) : 1894 - 1900
12345